❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Kjersti Flatmark's group ❭
Scroll to top

Home Dept. of Tumor Biology Kjersti Flatmark's group

  • Group members
  • From bench to bedside
  • Interventional clinical trials
  • Target discovery in peritoneal surface malignancies
  • Locally advanced and recurrent rectal cancer
  • Experimental treatment
  • Publications
  • News
  • Major collaborators

Recent publications

Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S (2025)
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
Cell Rep Med, 102350 (in press)
DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376

Andersson Y, Løvstakken E, Herud TM, Waagene S, Flatmark K, Fleten KG (2025)
Intraperitoneal Perfusion with Cisplatin or Mitomycin C Improves Survival in Mice Bearing Peritoneal Metastases from Ovarian Cancer
Ann Surg Oncol (in press)
DOI 10.1245/s10434-025-18025-x, PubMed 40788597

Al Haidari G, Solbakken AM, Åsli LM, Skovlund E, Undseth C, Guren MG (2025)
Treatment and outcomes for locally recurrent rectal cancer in Norway
Acta Oncol, 64, 784-792
DOI 10.2340/1651-226X.2025.42991, PubMed 40500960



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)